메뉴 건너뛰기




Volumn 121, Issue 2, 2015, Pages 319-329

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Author keywords

Chemoresistance; Combination therapy; Dendritic cell based vaccination; Glioblastoma multiforme; T cells; Temozolomide

Indexed keywords

DENDRITIC CELL VACCINE; GAMMA INTERFERON; TEMOZOLOMIDE; ALKYLATING AGENT; CANCER VACCINE; DACARBAZINE;

EID: 84925543609     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1635-7     Document Type: Article
Times cited : (50)

References (43)
  • 2
    • 84872387620 scopus 로고    scopus 로고
    • The efficacy of temozolomide for recurrent glioblastoma multiforme
    • COI: 1:CAS:528:DC%2BC3sXhtVWhtb%2FI, PID: 22680781
    • Chen C, Xu T, Lu Y, Chen J, Wu S (2013) The efficacy of temozolomide for recurrent glioblastoma multiforme. Eur J Neurol 20(2):223–230. doi:10.1111/j.1468-1331.2012.03778.x
    • (2013) Eur J Neurol , vol.20 , Issue.2 , pp. 223-230
    • Chen, C.1    Xu, T.2    Lu, Y.3    Chen, J.4    Wu, S.5
  • 4
    • 28044450847 scopus 로고    scopus 로고
    • Salvage temozolomide for prior temozolomide responders
    • COI: 1:CAS:528:DC%2BD2MXhtlWgt7bF, PID: 16270316
    • Franceschi E, Omuro AMP, Lassman AB, Demopoulos A, Nolan C, Abrey LE (2005) Salvage temozolomide for prior temozolomide responders. Cancer 104(11):2473–2476. doi:10.1002/cncr.21564
    • (2005) Cancer , vol.104 , Issue.11 , pp. 2473-2476
    • Franceschi, E.1    Omuro, A.M.P.2    Lassman, A.B.3    Demopoulos, A.4    Nolan, C.5    Abrey, L.E.6
  • 5
    • 67349125211 scopus 로고    scopus 로고
    • Rechallenge with temozolomide in patients with recurrent gliomas
    • COI: 1:CAS:528:DC%2BD1MXmtVKmsro%3D, PID: 19240962
    • Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, Hau P (2009) Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 256(5):734–741. doi:10.1007/s00415-009-5006-9
    • (2009) J Neurol , vol.256 , Issue.5 , pp. 734-741
    • Wick, A.1    Pascher, C.2    Wick, W.3    Jauch, T.4    Weller, M.5    Bogdahn, U.6    Hau, P.7
  • 6
    • 78349252105 scopus 로고    scopus 로고
    • Overview of cellular immunotherapy for patients with glioblastoma
    • Vauleon E, Avril T, Collet B, Mosser J, Quillien V (2010) Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010:1–18. doi:10.1155/2010/689171
    • (2010) Clin Dev Immunol , vol.2010 , pp. 1-18
    • Vauleon, E.1    Avril, T.2    Collet, B.3    Mosser, J.4    Quillien, V.5
  • 7
    • 84863270634 scopus 로고    scopus 로고
    • Cellular-based immunotherapies for patients with glioblastoma multiforme
    • PID: 22474481
    • Xu X, Stockhammer F, Schmitt M (2012) Cellular-based immunotherapies for patients with glioblastoma multiforme. Clin Dev Immunol 2012:764213. doi:10.1155/2012/764213
    • (2012) Clin Dev Immunol , vol.2012 , pp. 764213
    • Xu, X.1    Stockhammer, F.2    Schmitt, M.3
  • 8
    • 4143103624 scopus 로고    scopus 로고
    • Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
    • COI: 1:CAS:528:DC%2BD2cXmvFSlt74%3D, PID: 15328167
    • Wheeler CJ, Das A, Liu G, Yu JS, Black KL (2004) Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res 10(16):5316–5326. doi:10.1158/1078-0432.CCR-04-0497
    • (2004) Clin Cancer Res , vol.10 , Issue.16 , pp. 5316-5326
    • Wheeler, C.J.1    Das, A.2    Liu, G.3    Yu, J.S.4    Black, K.L.5
  • 9
    • 48149096721 scopus 로고    scopus 로고
    • Combined modality immunotherapy and chemotherapy: a new perspective
    • COI: 1:CAS:528:DC%2BD1cXovFyisbc%3D, PID: 18488219
    • Ramakrishnan R, Antonia S, Gabrilovich DI (2008) Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother 57(10):1523–1529. doi:10.1007/s00262-008-0531-4
    • (2008) Cancer Immunol Immunother , vol.57 , Issue.10 , pp. 1523-1529
    • Ramakrishnan, R.1    Antonia, S.2    Gabrilovich, D.I.3
  • 10
    • 24744452216 scopus 로고    scopus 로고
    • IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide
    • COI: 1:CAS:528:DC%2BD2MXpslaitL0%3D, PID: 16140920
    • Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J (2005) IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65(17):7573–7579. doi:10.1158/0008-5472.CAN-05-0036
    • (2005) Cancer Res , vol.65 , Issue.17 , pp. 7573-7579
    • Natsume, A.1    Ishii, D.2    Wakabayashi, T.3    Tsuno, T.4    Hatano, H.5    Mizuno, M.6    Yoshida, J.7
  • 11
    • 77952203844 scopus 로고    scopus 로고
    • Activated CD4 + T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo
    • COI: 1:CAS:528:DC%2BD1MXhtlKhtr3O, PID: 19846868
    • Radfar S, Wang Y, Khong HT (2009) Activated CD4 + T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo. J Immunol 183(10):6800–6807. doi:10.4049/jimmunol.0901747
    • (2009) J Immunol , vol.183 , Issue.10 , pp. 6800-6807
    • Radfar, S.1    Wang, Y.2    Khong, H.T.3
  • 12
    • 0038167151 scopus 로고    scopus 로고
    • Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma
    • COI: 1:CAS:528:DC%2BD3sXmt1Onu7Y%3D, PID: 12843792
    • Liu G, Khong HT, Wheeler CJ, Yu JS, Black KL, Ying H (2003) Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma. J Immunother 26(4):301–312
    • (2003) J Immunother , vol.26 , Issue.4 , pp. 301-312
    • Liu, G.1    Khong, H.T.2    Wheeler, C.J.3    Yu, J.S.4    Black, K.L.5    Ying, H.6
  • 13
    • 0030956966 scopus 로고    scopus 로고
    • Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas
    • COI: 1:CAS:528:DyaK2sXktFaksrk%3D, PID: 9176405
    • Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL, Hoon DS (1997) Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150(6):2143–2152
    • (1997) Am J Pathol , vol.150 , Issue.6 , pp. 2143-2152
    • Chi, D.D.1    Merchant, R.E.2    Rand, R.3    Conrad, A.J.4    Garrison, D.5    Turner, R.6    Morton, D.L.7    Hoon, D.S.8
  • 14
    • 0034688176 scopus 로고    scopus 로고
    • Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications
    • COI: 1:CAS:528:DC%2BD3cXpvVSntQ%3D%3D, PID: 10656687
    • Chu W, Pak BJ, Bani MR, Kapoor M, Lu SJ, Tamir A, Kerbel RS, Ben-David Y (2000) Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications. Oncogene 19(3):395–402. doi:10.1038/sj.onc.1203315
    • (2000) Oncogene , vol.19 , Issue.3 , pp. 395-402
    • Chu, W.1    Pak, B.J.2    Bani, M.R.3    Kapoor, M.4    Lu, S.J.5    Tamir, A.6    Kerbel, R.S.7    Ben-David, Y.8
  • 15
    • 0035691971 scopus 로고    scopus 로고
    • Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2
    • COI: 1:CAS:528:DC%2BD38XhsVWltbY%3D, PID: 11831643
    • Pak BJ, Chu W, Lu SJ, Kerbel RS, Ben-David Y (2001) Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2. Cancer Metastasis Rev 20(1–2):27–32
    • (2001) Cancer Metastasis Rev , vol.20 , Issue.1-2 , pp. 27-32
    • Pak, B.J.1    Chu, W.2    Lu, S.J.3    Kerbel, R.S.4    Ben-David, Y.5
  • 16
    • 0032697226 scopus 로고    scopus 로고
    • Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis
    • COI: 1:CAS:528:DyaK1MXntlaktLc%3D, PID: 10596909
    • Nishioka E, Funasaka Y, Kondoh H, Chakraborty AK, Mishima Y, Ichihashi M (1999) Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis. Melanoma Res 9(5):433–443
    • (1999) Melanoma Res , vol.9 , Issue.5 , pp. 433-443
    • Nishioka, E.1    Funasaka, Y.2    Kondoh, H.3    Chakraborty, A.K.4    Mishima, Y.5    Ichihashi, M.6
  • 17
    • 21344462768 scopus 로고    scopus 로고
    • Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy
    • COI: 1:CAS:528:DC%2BD2MXmvFemsb4%3D, PID: 15897911
    • Liu G, Akasaki Y, Khong HT, Wheeler CJ, Das A, Black KL, Yu JS (2005) Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy. Oncogene 24(33):5226–5234. doi:10.1038/sj.onc.1208519
    • (2005) Oncogene , vol.24 , Issue.33 , pp. 5226-5234
    • Liu, G.1    Akasaki, Y.2    Khong, H.T.3    Wheeler, C.J.4    Das, A.5    Black, K.L.6    Yu, J.S.7
  • 18
    • 0037083317 scopus 로고    scopus 로고
    • Quantitatively determined survivin expression levels are of prognostic value in human gliomas
    • COI: 1:CAS:528:DC%2BD38XitFOqurw%3D, PID: 11844831
    • Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20(4):1063–1068
    • (2002) J Clin Oncol , vol.20 , Issue.4 , pp. 1063-1068
    • Chakravarti, A.1    Noll, E.2    Black, P.M.3    Finkelstein, D.F.4    Finkelstein, D.M.5    Dyson, N.J.6    Loeffler, J.S.7
  • 22
    • 0030603987 scopus 로고    scopus 로고
    • Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
    • COI: 1:CAS:528:DyaK28XlsFWrtLg%3D, PID: 8841452
    • Romani N, Reider D, Heuer M, Ebner S, Kämpgen E, Eibl B, Niederwieser D, Schuler G (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196(2):137–151
    • (1996) J Immunol Methods , vol.196 , Issue.2 , pp. 137-151
    • Romani, N.1    Reider, D.2    Heuer, M.3    Ebner, S.4    Kämpgen, E.5    Eibl, B.6    Niederwieser, D.7    Schuler, G.8
  • 25
    • 0019365237 scopus 로고
    • Reporting results of cancer treatment
    • COI: 1:STN:280:DyaL3M7htFOltw%3D%3D, PID: 7459811
    • Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214
    • (1981) Cancer , vol.47 , Issue.1 , pp. 207-214
    • Miller, A.B.1    Hoogstraten, B.2    Staquet, M.3    Winkler, A.4
  • 27
    • 33846955124 scopus 로고    scopus 로고
    • Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
    • PID: 16944309
    • Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82(1):81–83. doi:10.1007/s11060-006-9241-y
    • (2007) J Neurooncol , vol.82 , Issue.1 , pp. 81-83
    • Chamberlain, M.C.1    Glantz, M.J.2    Chalmers, L.3    Van Horn, A.4    Sloan, A.E.5
  • 28
    • 84872705290 scopus 로고    scopus 로고
    • MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study
    • COI: 1:CAS:528:DC%2BC3sXktFCmug%3D%3D
    • Kimura T, McKolanis JR, Dzubinski LA, Islam K, Potter DM, Salazar AM, Schoen RE, Finn OJ (2013) MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) 6(1):18–26. doi:10.1158/1940-6207.CAPR-12-0275
    • (2013) Cancer Prev Res (Phila) , vol.6 , Issue.1 , pp. 18-26
    • Kimura, T.1    McKolanis, J.R.2    Dzubinski, L.A.3    Islam, K.4    Potter, D.M.5    Salazar, A.M.6    Schoen, R.E.7    Finn, O.J.8
  • 29
    • 84863096016 scopus 로고    scopus 로고
    • Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant
    • COI: 1:CAS:528:DC%2BC38XhtVSks7vP, PID: 22768182
    • Bauer M, Goldstein M, Heylmann D, Kaina B (2012) Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant. PLoS One 7(6):e39956. doi:10.1371/journal.pone.0039956
    • (2012) PLoS One , vol.7 , Issue.6 , pp. 39956
    • Bauer, M.1    Goldstein, M.2    Heylmann, D.3    Kaina, B.4
  • 30
    • 0033568012 scopus 로고    scopus 로고
    • Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta
    • COI: 1:CAS:528:DyaK1MXlvV2lt7s%3D, PID: 10477621
    • Schmidt M, Pauels HG, Lügering N, Lügering A, Domschke W, Kucharzik T (1999) Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol 163(6):3484–3490
    • (1999) J Immunol , vol.163 , Issue.6 , pp. 3484-3490
    • Schmidt, M.1    Pauels, H.G.2    Lügering, N.3    Lügering, A.4    Domschke, W.5    Kucharzik, T.6
  • 33
    • 80052738137 scopus 로고    scopus 로고
    • Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of radiation therapy oncology group-recursive partitioning analysis in the IMRT and temozolomide era
    • PID: 21181233
    • Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen Y-F, Huq MS (2011) Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of radiation therapy oncology group-recursive partitioning analysis in the IMRT and temozolomide era. J Neurooncol 104(1):339–349. doi:10.1007/s11060-010-0499-8
    • (2011) J Neurooncol , vol.104 , Issue.1 , pp. 339-349
    • Paravati, A.J.1    Heron, D.E.2    Landsittel, D.3    Flickinger, J.C.4    Mintz, A.5    Chen, Y.-F.6    Huq, M.S.7
  • 34
    • 84870982871 scopus 로고    scopus 로고
    • Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
    • PID: 22565485
    • De Vleeschouwer S, Ardon H, Van Calenbergh F, Sciot R, Wilms G, Van Loon J, Goffin J, Van Gool S (2012) Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination. Cancer Immunol Immunother 61(11):2105–2112. doi:10.1007/s00262-012-1271-z
    • (2012) Cancer Immunol Immunother , vol.61 , Issue.11 , pp. 2105-2112
    • De Vleeschouwer, S.1    Ardon, H.2    Van Calenbergh, F.3    Sciot, R.4    Wilms, G.5    Van Loon, J.6    Goffin, J.7    Van Gool, S.8
  • 35
    • 23044479028 scopus 로고    scopus 로고
    • Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
    • COI: 1:CAS:528:DC%2BD2MXmvFSmur0%3D, PID: 16061868
    • Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin J-W, Chute DJ, Mischel PS, Cloughesy TF, Roth MD (2005) Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 11(15):5515–5525. doi:10.1158/1078-0432.CCR-05-0464
    • (2005) Clin Cancer Res , vol.11 , Issue.15 , pp. 5515-5525
    • Liau, L.M.1    Prins, R.M.2    Kiertscher, S.M.3    Odesa, S.K.4    Kremen, T.J.5    Giovannone, A.J.6    Lin, J.-W.7    Chute, D.J.8    Mischel, P.S.9    Cloughesy, T.F.10    Roth, M.D.11
  • 37
    • 35948930300 scopus 로고    scopus 로고
    • Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
    • COI: 1:CAS:528:DC%2BD2sXhsVersbrJ, PID: 17645496
    • Kim C-H, Woo S-J, Park J-S, Kim H-S, Park M-Y, Park S-D, Hong Y-K, Kim T-G (2007) Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. Immunology 122(4):615–622. doi:10.1111/j.1365-2567.2007.02680.x
    • (2007) Immunology , vol.122 , Issue.4 , pp. 615-622
    • Kim, C.-H.1    Woo, S.-J.2    Park, J.-S.3    Kim, H.-S.4    Park, M.-Y.5    Park, S.-D.6    Hong, Y.-K.7    Kim, T.-G.8
  • 38
    • 59849125142 scopus 로고    scopus 로고
    • SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity
    • COI: 1:CAS:528:DC%2BD1MXisVeqsbo%3D, PID: 18948646
    • Gangemi RMR, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27(1):40–48. doi:10.1634/stemcells.2008-0493
    • (2009) Stem Cells , vol.27 , Issue.1 , pp. 40-48
    • Gangemi, R.M.R.1    Griffero, F.2    Marubbi, D.3    Perera, M.4    Capra, M.C.5    Malatesta, P.6    Ravetti, G.L.7    Zona, G.L.8    Daga, A.9    Corte, G.10
  • 39
    • 83355166283 scopus 로고    scopus 로고
    • Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
    • COI: 1:CAS:528:DC%2BC3MXhsF2lt7%2FP, PID: 22098779
    • Yang Y-P, Chien Y, Chiou G-Y, Cherng J-Y, Wang M-L, Lo W-L, Chang Y-L, Huang P-I, Chen Y-W, Shih Y-H, Chen M-T, Chiou S-H (2012) Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 33(5):1462–1476. doi:10.1016/j.biomaterials.2011.10.071
    • (2012) Biomaterials , vol.33 , Issue.5 , pp. 1462-1476
    • Yang, Y.-P.1    Chien, Y.2    Chiou, G.-Y.3    Cherng, J.-Y.4    Wang, M.-L.5    Lo, W.-L.6    Chang, Y.-L.7    Huang, P.-I.8    Chen, Y.-W.9    Shih, Y.-H.10    Chen, M.-T.11    Chiou, S.-H.12
  • 41
    • 84873989551 scopus 로고    scopus 로고
    • Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
    • COI: 1:CAS:528:DC%2BC3sXitlCis7c%3D, PID: 23377664
    • Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM (2013) Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother 36(2):152–157. doi:10.1097/CJI.0b013e3182811ae4
    • (2013) J Immunother , vol.36 , Issue.2 , pp. 152-157
    • Prins, R.M.1    Wang, X.2    Soto, H.3    Young, E.4    Lisiero, D.N.5    Fong, B.6    Everson, R.7    Yong, W.H.8    Lai, A.9    Li, G.10    Cloughesy, T.F.11    Liau, L.M.12
  • 43
    • 84877355954 scopus 로고    scopus 로고
    • Dendritic cell immunotherapy
    • COI: 1:CAS:528:DC%2BC3sXpsFCntrk%3D, PID: 23651191
    • Sabado RL, Bhardwaj N (2013) Dendritic cell immunotherapy. Ann N Y Acad Sci 1284:31–45. doi:10.1111/nyas.12125
    • (2013) Ann N Y Acad Sci , vol.1284 , pp. 31-45
    • Sabado, R.L.1    Bhardwaj, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.